Average Co-Inventor Count = 2.35
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University System of Maryland (8 from 1,910 patents)
2. The United States Government As Represented by the Department of Veterans Affairs (3 from 879 patents)
3. Other (2 from 831,952 patents)
4. Gen1e Lifesciences Inc. (1 from 8 patents)
10 patents:
1. 12404259 - Inhibitors of extracellular signal-regulated kinase
2. 12202810 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
3. 11911393 - Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
4. 11911392 - Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
5. 11718595 - Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors
6. 11357781 - Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
7. 11078171 - Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
8. 9198763 - Surgical technique using a contoured allograft cartilage as a spacer of the carpo-metacarpal joint of the thumb or tarso-metatarsal joint of the toe
9. 9115122 - Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)
10. 8834568 - Surgical technique using a contoured allograft cartilage as a spacer of the carpo-metacarpal joint of the thumb or tarso-metatarsal joint of the toe